Get started
Adial Pharmaceuticals, IncAdial Pharmaceuticals, IncAdial Pharmaceuticals, Inc

Adial Pharmaceuticals, Inc

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Forecast Seasonals

ADIL chart


Full chart

ADIL upcoming earnings


Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪5.68 M‬ USD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−1.6240 USD
Net income (FY)
‪−13.20 M‬ USD
Revenue (FY)
0.00 USD
Shares float
‪7.76 M‬
Beta (1Y)
0.78

Employees


Employees (FY)
7
Change (1Y)
0
Revenue / Employee (1Y)
0.00 USD
Net income / Employee (1Y)
‪−1.89 M‬ USD

About Adial Pharmaceuticals, Inc


Sector
Health Technology
Industry
Pharmaceuticals: Major
CEO
Cary J. Claiborne
Website
adialpharma.com
Headquarters
Glen Allen
Founded
2010
FIGI
BBG00HNGDTR4
Adial Pharmaceuticals, Inc. engages in the development of therapeutics for the treatment or prevention of addiction and related disorders. It offers the AD04, a selective serotonin-3 antagonist. The company was founded by Bankole A. Johnson and William B. Stilley, III in November 2010 and is headquartered in Glen Allen, VA.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

ADIL news



Ideas



See all ideas 

Technicals


Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Check out other big names from the same industry as ADIL.

Frequently Asked Questions


The current price of ADIL is 0.6898 USD — it has decreased by −4.26% in the past 24 hours. Watch Adial Pharmaceuticals, Inc stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Adial Pharmaceuticals, Inc stocks are traded under the ticker ADIL.
ADIL stock has risen by 1.99% compared to the previous week, the month change is a −0.23% fall, over the last year Adial Pharmaceuticals, Inc has showed a −51.42% decrease.
We've gathered analysts' opinions on Adial Pharmaceuticals, Inc future price: according to them, ADIL price has a max estimate of 6.00 USD and a min estimate of 4.00 USD. Watch ADIL chart and read a more detailed Adial Pharmaceuticals, Inc stock forecast: see what analysts think of Adial Pharmaceuticals, Inc and suggest that you do with its stocks.
ADIL reached its all-time high on Jan 15, 2019 with the price of 236.0000 USD, and its all-time low was 0.5704 USD and was reached on May 9, 2025. View more price dynamics on ADIL chart.
See other stocks reaching their highest and lowest prices.
ADIL stock is 9.09% volatile and has beta coefficient of 0.78. Track Adial Pharmaceuticals, Inc stock price on the chart and check out the list of the most volatile stocks — is Adial Pharmaceuticals, Inc there?
Today Adial Pharmaceuticals, Inc has the market capitalization of ‪5.68 M‬, it has decreased by −2.70% over the last week.
Yes, you can track Adial Pharmaceuticals, Inc financials in yearly and quarterly reports right on TradingView.
Adial Pharmaceuticals, Inc is going to release the next earnings report on Aug 13, 2025. Keep track of upcoming events with our Earnings Calendar.
ADIL earnings for the last quarter are −0.34 USD per share, whereas the estimation was −0.35 USD resulting in a 4.23% surprise. The estimated earnings for the next quarter are −0.25 USD per share. See more details about Adial Pharmaceuticals, Inc earnings.
Adial Pharmaceuticals, Inc revenue for the last quarter amounts to 0.00 USD, matching the estimated figure, and no changes in revenue are expected for the next quarter.
ADIL net income for the last quarter is ‪−2.23 M‬ USD, while the quarter before that showed ‪−2.07 M‬ USD of net income which accounts for −7.63% change. Track more Adial Pharmaceuticals, Inc financial stats to get the full picture.
No, ADIL doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of May 23, 2025, the company has 7 employees. See our rating of the largest employees — is Adial Pharmaceuticals, Inc on this list?
Like other stocks, ADIL shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Adial Pharmaceuticals, Inc stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Adial Pharmaceuticals, Inc technincal analysis shows the neutral today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Adial Pharmaceuticals, Inc stock shows the sell signal. See more of Adial Pharmaceuticals, Inc technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.